Through enrichment analysis and immune score, Jiang et al.98 identified that the expression level of STC2 was significantly positively correlated with the infiltration level of B cells, T cells and other immune cells in various cancer cells, and was significantly correlated with the sensitivity towards certain drugs, and suggested STC2 as a promising target for tumor immunotherapy. Here, STC2 is linked to neoplasm.